Platelet-rich plasma (PRP): methodological aspects and clinical applications.
about
Platelet gel: a new therapeutic tool with great potentialApplication of platelet-rich plasma with stem cells in bone and periodontal tissue engineeringConstruction of tissue-engineered bone using a bioreactor and platelet-rich plasma.Comparison between Conventional Mechanical Fixation and Use of Autologous Platelet Rich Plasma (PRP) in Wound Beds Prior to Resurfacing with Split Thickness Skin Graft.Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances.Platelet-rich plasma for bone healing and regeneration.Evaluation of subcutaneous infiltration of autologous platelet-rich plasma on skin-wound healing in dogs.Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin AgingDifferential effect of platelet-rich plasma fractions on β1-integrin signaling, collagen biosynthesis, and prolidase activity in human skin fibroblasts.The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds).Platelet-rich plasma therapy: A novel application in regenerative medicine.Platelet-Rich Plasma Derived Growth Factors Contribute to Stem Cell Differentiation in Musculoskeletal Regeneration.Platelet-rich plasma, the ultimate secret for youthful skin elixir and hair growth triggering.The use of platelet-rich plasma to treat chronic tendinopathies: A technical analysis.The use of platelet-rich plasma (PRP) in the treatment of gastrocnemius strains: a retrospective observational study.Platelet-rich plasma (PRP) and adipose-derived mesenchymal stem cells: stimulatory effects on proliferation and migration of fibroblasts and keratinocytes in vitro.Platelet Rich Plasma: a short overview of certain bioactive components.Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan.Can Plasma Rich in Growth Factors Be Safe for Parental Use? A Safety Study in the Canine Model
P2860
Q26739936-070E8089-9FB6-4D2B-AE25-DB0CB5DCFB03Q28076740-461AA227-4F2A-4465-8F03-7029F6BCFAA5Q33837493-A7F4670B-2E12-45F7-B1EB-79FF91A14926Q34984296-2745EA40-EE17-4F02-A9D1-88F807C24033Q38514835-06AA31E6-ACA2-405F-B8A7-2978C4BA02FEQ38631585-E58E53A6-2FCF-4225-9660-62D3AD92A7CAQ38936747-16731E1A-7E1D-41CC-AD41-A2DD90743D0FQ39100850-7ED1A153-4D1E-4DFE-B45F-955555964E69Q40997604-C25EF5BF-E37D-4C73-B664-78E6C22D97A5Q41623058-946B0F82-DC6B-4BCD-AAA8-20EB1F62121DQ42143147-9D200FFC-25DD-4337-89D3-07D1F989EDD6Q46480667-7729A5F2-0B98-4EE4-AB44-BADA57D64399Q46730618-2241598E-4411-43FB-9A49-2F575E0FAB1BQ47268481-6917BB6B-1101-48DD-99F9-C06DF1A27910Q50140659-58B21FF4-0DF8-4977-8CA3-E65271B701BFQ51256663-01067920-70C7-4A89-BB26-FD29EB777195Q53648939-430613DF-0DA2-44B7-ABF7-E81D5C01E5CBQ55318084-9AB9442D-B1E7-4BDC-9591-F1EDB95B27B2Q58749611-B9D53419-0DC8-4F92-B977-F2BDF62127B9
P2860
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
@ast
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
@en
type
label
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
@ast
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
@en
prefLabel
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
@ast
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
@en
P2093
P2860
P1433
P1476
Platelet-rich plasma (PRP): methodological aspects and clinical applications.
@en
P2093
Isabel Cristina Cherici Camargo
Laís Fernanda Marques
Lucinéia dos Santos
Nemi Sabeh Junior
Talita Stessuk
P2860
P304
P356
10.3109/09537104.2014.881991
P577
2014-02-10T00:00:00Z